Trials / Unknown
UnknownNCT02947191
Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation
The Safety and Efficacy Assessment of Collagen Membrane Combined With Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Nasal Septum Perforation
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Chinese Academy of Sciences · Other Government
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of collagen membrane combined with human clinical grade umbilical cord mesenchymal stem cells(HUC-MSCs) transplantation in patients with chronic nasal septum perforation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Collagen membrane + HUC-MSCs | After separating bilateral nasal septum mucosas via septum reconstruction incision under endoscopy, the clinical grade HUC-MSCs combined with collagen membrane will be transplanted between the bilateral nasal septum mucosas and fixed. The patients will be treated with antibiotics for 1 week, and with naristillae menthae compositae, mucus promoting agent and other drugs for improving microcirculation for 1 month. |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2016-10-27
- Last updated
- 2021-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02947191. Inclusion in this directory is not an endorsement.